BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34187164)

  • 1. Characteristics and Outcomes of Women Developing Heart Failure After Early Stage Breast Cancer Chemotherapy: A Population-Based Matched Cohort Study.
    Abdel-Qadir H; Tai F; Croxford R; Austin PC; Amir E; Calvillo-Argüelles O; Ross H; Lee DS; Thavendiranathan P
    Circ Heart Fail; 2021 Jul; 14(7):e008110. PubMed ID: 34187164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statin Exposure and Risk of Heart Failure After Anthracycline- or Trastuzumab-Based Chemotherapy for Early Breast Cancer: A Propensity Score‒Matched Cohort Study.
    Abdel-Qadir H; Bobrowski D; Zhou L; Austin PC; Calvillo-Argüelles O; Amir E; Lee DS; Thavendiranathan P
    J Am Heart Assoc; 2021 Jan; 10(2):e018393. PubMed ID: 33401953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Risk of Heart Failure and Other Cardiovascular Hospitalizations After Early Stage Breast Cancer: A Matched Cohort Study.
    Abdel-Qadir H; Thavendiranathan P; Austin PC; Lee DS; Amir E; Tu JV; Fung K; Anderson GM
    J Natl Cancer Inst; 2019 Aug; 111(8):854-862. PubMed ID: 30715404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study.
    Bowles EJ; Wellman R; Feigelson HS; Onitilo AA; Freedman AN; Delate T; Allen LA; Nekhlyudov L; Goddard KA; Davis RL; Habel LA; Yood MU; McCarty C; Magid DJ; Wagner EH;
    J Natl Cancer Inst; 2012 Sep; 104(17):1293-305. PubMed ID: 22949432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast Cancer Therapy-Related Cardiac Dysfunction in Adult Women Treated in Routine Clinical Practice: A Population-Based Cohort Study.
    Thavendiranathan P; Abdel-Qadir H; Fischer HD; Camacho X; Amir E; Austin PC; Lee DS
    J Clin Oncol; 2016 Jul; 34(19):2239-46. PubMed ID: 27091709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of heart failure after systemic treatment for early breast cancer: results of a cohort study.
    Jacobse JN; Schaapveld M; Boekel NB; Hooning MJ; Jager A; Baaijens MHA; Hauptmann M; Russell NS; Rutgers EJT; Aleman BMP; Sonke GS; van Leeuwen FE
    Breast Cancer Res Treat; 2021 Jan; 185(1):205-214. PubMed ID: 32964358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Early-Stage Breast Cancer and Subsequent Chemotherapy With Risk of Atrial Fibrillation.
    Abdel-Qadir H; Thavendiranathan P; Fung K; Amir E; Austin PC; Anderson GS; Lee DS
    JAMA Netw Open; 2019 Sep; 2(9):e1911838. PubMed ID: 31539076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac safety of non-anthracycline trastuzumab-based therapy for HER2-positive breast cancer.
    Yu AF; Mukku RB; Verma S; Liu JE; Oeffinger KC; Steingart RM; Hudis CA; Dang CT
    Breast Cancer Res Treat; 2017 Nov; 166(1):241-247. PubMed ID: 28710537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Risk of Heart Failure in Breast Cancer Patients After Adjuvant Chemotherapy With or Without Trastuzumab.
    Banke A; Fosbøl EL; Ewertz M; Videbæk L; Dahl JS; Poulsen MK; Cold S; Jensen MB; Gislason GH; Schou M; Møller JE
    JACC Heart Fail; 2019 Mar; 7(3):217-224. PubMed ID: 30819377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart failure after treatment for breast cancer.
    Boekel NB; Duane FK; Jacobse JN; Hauptmann M; Schaapveld M; Sonke GS; Gietema JA; Hooning MJ; Seynaeve CM; Maas AHEM; Darby SC; Aleman BMP; Taylor CW; van Leeuwen FE
    Eur J Heart Fail; 2020 Feb; 22(2):366-374. PubMed ID: 31721395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Temporal Risk of Heart Failure Associated With Adjuvant Trastuzumab in Breast Cancer Patients: A Population Study.
    Goldhar HA; Yan AT; Ko DT; Earle CC; Tomlinson GA; Trudeau ME; Krahn MD; Krzyzanowska MK; Pal RS; Brezden-Masley C; Gavura S; Lien K; Chan KK
    J Natl Cancer Inst; 2016 Jan; 108(1):. PubMed ID: 26476433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of statin therapy on the risk for incident heart failure in patients with breast cancer receiving anthracycline chemotherapy: an observational clinical cohort study.
    Seicean S; Seicean A; Plana JC; Budd GT; Marwick TH
    J Am Coll Cardiol; 2012 Dec; 60(23):2384-90. PubMed ID: 23141499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiotoxicity and Cardiac Monitoring Among Chemotherapy-Treated Breast Cancer Patients.
    Henry ML; Niu J; Zhang N; Giordano SH; Chavez-MacGregor M
    JACC Cardiovasc Imaging; 2018 Aug; 11(8):1084-1093. PubMed ID: 30092967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardioprotective effect of β-adrenoceptor blockade in patients with breast cancer undergoing chemotherapy: follow-up study of heart failure.
    Seicean S; Seicean A; Alan N; Plana JC; Budd GT; Marwick TH
    Circ Heart Fail; 2013 May; 6(3):420-6. PubMed ID: 23425978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating neuregulin during the transition from stage A to stage B/C heart failure in a breast cancer cohort.
    Geisberg CA; Abdallah WM; da Silva M; Silverstein C; Smith HM; Abramson V; Mayer I; Means-Powell J; Freehardt D; White B; Lenihan D; Sawyer DB
    J Card Fail; 2013 Jan; 19(1):10-5. PubMed ID: 23273589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiotoxicity among socioeconomically marginalized breast cancer patients.
    Lu Y; Gehr AW; Anikpo I; Meadows RJ; Craten KJ; Narra K; Lingam A; Kamath S; Tanna B; Ghabach B; Ojha RP
    Breast Cancer Res Treat; 2022 Oct; 195(3):401-411. PubMed ID: 35971056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity As a Risk Factor for Anthracyclines and Trastuzumab Cardiotoxicity in Breast Cancer: A Systematic Review and Meta-Analysis.
    Guenancia C; Lefebvre A; Cardinale D; Yu AF; Ladoire S; Ghiringhelli F; Zeller M; Rochette L; Cottin Y; Vergely C
    J Clin Oncol; 2016 Sep; 34(26):3157-65. PubMed ID: 27458291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors predicting trastuzumab-related cardiotoxicity in a real-world population of women with HER2+ breast cancer.
    Naumann D; Rusius V; Margiotta C; Nevill A; Carmichael A; Rea D; Sintler M
    Anticancer Res; 2013 Apr; 33(4):1717-20. PubMed ID: 23564821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of heart failure or cardiomyopathy after adjuvant trastuzumab therapy for breast cancer.
    Chen J; Long JB; Hurria A; Owusu C; Steingart RM; Gross CP
    J Am Coll Cardiol; 2012 Dec; 60(24):2504-12. PubMed ID: 23158536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trastuzumab-Related Cardiotoxic Effects in Taiwanese Women: A Nationwide Cohort Study.
    Chien HC; Kao Yang YH; Bai JP
    JAMA Oncol; 2016 Oct; 2(10):1317-1325. PubMed ID: 27310478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.